VBI Vaccines and Agenus Announce Collaboration to Evaluate VBI-1901 in Combination with Anti-PD-1 Balstilimab in a Phase 2 Study in Primary Glioblastoma Patients
Stock Information for VBI Vaccines Inc.
Loading
Please wait while we load your information from QuoteMedia.